Cyclin-dependent kinase subunit 2 (cks2) as a prognostic marker for stages i-iii invasive non-mucinous lung adenocarcinoma and its role in affecting drug sensitivity

HIGHLIGHTS

• who: Junkai Feng et al. from the Department Pathology, The Second Affiliated Hospital Zhengzhou University, Zhengzhou, China have published the Article: Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity, in the Journal: Cells 2022, 11, 2611. of 20/Dec/2021
• what: In contrast to other studies on the expression of CKS2 in LUAD , the primary focus of the research was on invasive lung adenocarcinoma, the most common type of LUAD.
• how: The results showed that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.